4.5 Editorial Material

Carbonic anhydrase inhibitors: an editorial

Journal

EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 23, Issue 6, Pages 677-679

Publisher

INFORMA HEALTHCARE
DOI: 10.1517/13543776.2013.778246

Keywords

anticancer; antiglaucoma; anti-obesity; carbonic anhydrase; coumarin; dithiocarbamate; diuretic; inhibitor; polyamine; sulfonamide

Ask authors/readers for more resources

This issue of Expert Opinion on Therapeutic Patents is dedicated to carbonic anhydrase (CA, EC 4.2.1.1) inhibitors (CAIs), a highly dynamic research topic in the last years. Several review articles and patent analyses on diuretics and antiglaucoma, antiepileptic, anti-obesity and anticancer agents belonging to the pharmacological class of the CAIs are presented, together with a review on bacterial, fungal and protozoan CAs and their inhibition as a novel means of designing anti-infectives.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available